Dianthus Therapeutics
DNTH
DNTH
54 hedge funds and large institutions have $125M invested in Dianthus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 10 closing their positions.
Holders
54
Holders Change
+3
Holders Change %
+5.88%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
14
Increased
15
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TGI
1
TRV GP IV
Boston,
Massachusetts
|
$45.6M |
2 |
EAM
2
Eventide Asset Management
Boston,
Massachusetts
|
$14.8M |
3 |
CC
3
Casdin Capital
New York
|
$15.1M |
4 |
4
BlackRock
New York
|
$3.17M |
5 |
5
Bessemer Group
Woodbridge,
New Jersey
|
$1.35M |